Ergo Science (Ergo Science) EBIT per Share : $-3,021.00 (TTM As of Sep. 2006)

View and export this data going back to . Start your Free Trial

What is Ergo Science EBIT per Share?

Ergo Science's EBIT per Share for the three months ended in Sep. 2006 was $-123.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2006 was $-3,021.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ergo Science's EBIT per Share or its related term are showing as below:

ERGN's 3-Year EBIT Growth Rate is not ranked ^*
in the Business Services industry.
Industry Median: 11.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Ergo Science's EBIT for the three months ended in Sep. 2006 was $-0.12 Mil.

Ergo Science EBIT per Share Historical Data

The historical data trend for Ergo Science's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science EBIT per Share Chart

Ergo Science Annual Data

Trend

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

EBIT per Share

Get a 7-Day Free Trial

-2,512.00

-1,426.76

-4,235.21

1,373.24

-2,589.00

Ergo Science Quarterly Data
	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06
EBIT per Share	Get a 7-Day Free Trial															-1,101.41	-	-1,774.00	-1,124.00	-123.00

Ergo Science EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ergo Science's EBIT per Share for the fiscal year that ended in Dec. 2005 is calculated as

	EBIT per Share		(A: Dec. 2005 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.589	/	0.001
=	-2,589.00

Ergo Science's EBIT per Share for the quarter that ended in Sep. 2006 is calculated as

	EBIT per Share		(Q: Sep. 2006 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.123	/	0.001
=	-123.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3,021.00

Ergo Science (GREY:ERGN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ergo Science EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ergo Science's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ergo Science (Ergo Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223

Website

http://www.ergoscience.com

Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.

Executives

Citigroup Inc	director	388 GREENWICH STREET, NEW YORK NY 10013
Iticorp	director	399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp	director	ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co	director	336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd	director	399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines